Stroeer SE & Co. KGaA (0MYZ)
London Stock Exchange · UK · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 36.76 |
|---|---|
| 52-week range | 29.05 – 42.00 |
| Return, 1 month / 3 months | −1.7% / +0.8% |
| Return, 1 year / 3 years | −3.3% / −3.7% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 45 |
| Volatility (1 year) | 33.1% |
| Worst drawdown (1 year) | -23.4% |
| Average daily value traded | 0.42M EUR |
| Dividend yield | 5.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Stroeer SE & Co. KGaA is a German advertising company based in Cologne. It rents advertising space on billboards, street furniture and transport sites, and runs digital screens in public places, serving brands and agencies that want to reach people outdoors. The company also operates online media properties and offers related marketing services, combining classic out-of-home advertising with digital channels for its advertising customers.
Stroeer SE & Co. KGaA trades under the code 0MYZ on the London Stock Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Stroeer SE & Co. KGaA (0MYZ) trades on the London Stock Exchange in UK. It last closed at EUR 36.76 on 27 October 2026.
Its price-based Market X-Ray is 58 out of 100 (a fair price profile), ranking 1,517 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 3.3% and over the last three months it rose 0.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 68 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 5.0% | ||
| From 52-week high | -10.4% | ||
| Momentum | 54 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 0.8% | ||
| 6-month return | 7.1% | ||
| 12-month return, skipping the last month | -1.6% | ||
| Stability (higher is calmer) | 59 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 33.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -23.4% | ||
| Liquidity | 44 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.42M EUR | ||
| Zero-volume days | 8.3% | ||
| Income | 59 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.0% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −2.6% |
|---|---|
| 1 month | −1.7% |
| 3 months | +0.8% |
| 6 months | +7.1% |
| 1 year | −3.3% |
| 3 years | −3.7% |
| 5 years | −36.8% |
Signals
| 50-day / 200-day average | 37.51 / 35.01 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.76 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 4 Jun 2026 | EUR 1.8500 |
| 5 Jun 2025 | EUR 2.3000 |
| 12 Jun 2024 | EUR 1.8500 |
| 6 Jul 2023 | EUR 1.8500 |
| 23 Jun 2022 | EUR 2.2500 |
| 6 Sep 2021 | EUR 2.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.